ARTICLE | Management Tracks
Rawat becomes president, CBO at Fusion
Plus: Sporos, Ajax, Nanocan and NeuroSense
September 29, 2021 11:02 PM UTC
Mohit Rawat became president and CBO at Fusion Pharmaceuticals Inc. (NASDAQ:FUSN). Rawat joins the radiopharmaceuticals company from the oncology division of Novartis AG (SIX:NOVN; NYSE:NVS), where he was VP and global disease lead.
Cancer, fibrosis, inflammation and immune disease company Sporos Bioventures LLC hired Amit Rakhit as CEO. Rakhit comes from Ovid Therapeutics Inc. (NASDAQ:OVID), where he was president and CMO. He previously held various senior roles at Biogen Inc. (NASDAQ:BIIB) and Bristol Myers Squibb Co. (NYSE:BMY)...